Cannabis Stocks To Keep An Eye On – June 10th

Evogene, Incannex Healthcare, Turning Point Brands, Canopy Growth, and Indivior are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are equity shares of publicly traded companies that operate within the legal cannabis industry, including cultivation, processing, distribution and ancillary services. They tend to be highly volatile and closely tied to shifts in regulation, market acceptance and broader investor sentiment toward marijuana legalization. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Evogene (EVGN)

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.

Shares of Evogene stock traded up $0.94 during trading on Tuesday, hitting $2.07. 80,824,814 shares of the company were exchanged, compared to its average volume of 522,040. The firm’s fifty day moving average price is $1.13 and its 200 day moving average price is $1.38. Evogene has a 1-year low of $0.95 and a 1-year high of $7.19. The firm has a market capitalization of $11.13 million, a P/E ratio of -0.46 and a beta of 1.55.

Incannex Healthcare (IXHL)

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.

Shares of IXHL stock traded up $0.01 during trading on Tuesday, reaching $0.20. The company’s stock had a trading volume of 158,675,319 shares, compared to its average volume of 12,652,822. The company has a quick ratio of 1.65, a current ratio of 1.80 and a debt-to-equity ratio of 2.47. Incannex Healthcare has a one year low of $0.08 and a one year high of $3.55. The business has a fifty day moving average price of $0.37 and a 200-day moving average price of $1.14. The company has a market cap of $5.98 million, a price-to-earnings ratio of -0.15 and a beta of 7.63.

Turning Point Brands (TPB)

Turning Point Brands, Inc., together with its subsidiaries, manufactures, markets, and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker’s Products, and Creative Distribution Solutions. Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products, as well as lighters and other accessories under the Zig-Zag brand.

Shares of TPB stock traded down $0.23 during trading on Tuesday, reaching $74.59. 134,820 shares of the company’s stock were exchanged, compared to its average volume of 176,928. The firm’s fifty day moving average price is $65.83 and its 200-day moving average price is $63.08. The company has a quick ratio of 1.78, a current ratio of 4.21 and a debt-to-equity ratio of 1.33. The stock has a market capitalization of $1.34 billion, a PE ratio of 29.60 and a beta of 0.76. Turning Point Brands has a twelve month low of $30.61 and a twelve month high of $81.16.

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Shares of NASDAQ CGC traded down $0.09 during midday trading on Tuesday, reaching $1.54. The company’s stock had a trading volume of 3,796,911 shares, compared to its average volume of 5,950,543. The business’s 50 day moving average price is $1.33 and its two-hundred day moving average price is $1.90. Canopy Growth has a fifty-two week low of $0.77 and a fifty-two week high of $8.65. The company has a debt-to-equity ratio of 0.74, a quick ratio of 2.58 and a current ratio of 3.52. The company has a market cap of $282.23 million, a P/E ratio of -0.40 and a beta of 0.75.

Indivior (INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

NASDAQ INDV traded up $0.42 on Tuesday, hitting $13.85. 384,426 shares of the company’s stock were exchanged, compared to its average volume of 1,080,273. The stock has a 50-day moving average of $10.94 and a 200-day moving average of $10.89. The stock has a market cap of $1.91 billion, a price-to-earnings ratio of -39.54 and a beta of 0.66. Indivior has a 52 week low of $7.33 and a 52 week high of $17.09.